Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 8.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 540,089 shares of the company's stock after buying an additional 40,625 shares during the period. The Manufacturers Life Insurance Company owned 0.43% of Henry Schein worth $39,372,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of HSIC. Cromwell Holdings LLC raised its position in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after acquiring an additional 170 shares in the last quarter. Summit Securities Group LLC bought a new position in Henry Schein in the second quarter worth about $31,000. Beach Investment Counsel Inc. PA purchased a new stake in shares of Henry Schein during the second quarter valued at about $37,000. Blue Trust Inc. boosted its holdings in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after buying an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its position in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after buying an additional 346 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Analysts Set New Price Targets

HSIC has been the subject of several recent analyst reports. Robert W. Baird lowered their target price on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research note on Wednesday, August 7th. Barrington Research reissued an "outperform" rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. JPMorgan Chase & Co. reduced their target price on Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a research report on Monday, August 12th. UBS Group lowered their price target on Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. Finally, Evercore ISI lifted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. Six investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and an average target price of $79.38.

Henry Schein Stock Performance

Shares of HSIC stock traded down $0.61 on Friday, hitting $77.05. The company had a trading volume of 608,537 shares, compared to its average volume of 1,397,171. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.61 billion, a P/E ratio of 31.96, a price-to-earnings-growth ratio of 2.23 and a beta of 0.87. The company has a 50-day moving average price of $71.36 and a 200-day moving average price of $69.89.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the company posted $1.32 earnings per share. As a group, equities research analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.